Tissue engineering of a vascularized bone graft of critical size with an osteogenic and angiogenic factor-based in vivo bioreactor.

Engineering a large vascularized bone graft is a much greater challenge than engineering small bone tissues. Although this is essentially feasible through an osteogenic factor-based in vivo bioreactor technique, the ossification needs improving. This study was aimed to investigate the possibility and efficacy of ectopic cultivation of sizeable bone grafts with large angiogenic and osteogenic factor-loaded natural bovine bone mineral (NBBM) scaffolds. For this purpose, six groups of sizeable composite scaffolds were constructed, consisting of a titanium mesh cage of NBBM or a mixture of NBBM/autogenous bone particles (AB), which were preloaded with 660 μg recombinant human bone morphogenetic protein-7 (rhBMP-7) and/or 4 μg recombinant human vascular endothelial growth factor165 (rhVEGF165). The scaffolds were implanted in bilateral latissimus dorsi muscles in eight pigs to construct in vivo bioreactors. Sequential fluorescence labeling was then applied to trace bone formation at the early stage. The implants were retrieved 12 weeks later. The undecalcified sections were observed in turn under the fluorescence microscope and light microscope to investigate early stage osteogenesis and histology. Moreover, new bone density (BD) was measured with histomorphometry. Compared with rhBMP-7-delivered NBBM scaffolds, rhVEGF165/rhBMP-7-delivered NBBM scaffolds were with more intense intra-scaffold osteogenesis at the early stage and the ultimate sizeable bone grafts of microstructurally more lamellae and trabeculae, and quantitatively higher BD (31.93% vs. 22.37%, p<0.01). This study demonstrated that as for the endocultivation of a large bone graft with bioactive factor-based in vivo bioreactor technique, dual delivery of rhVEGF165/rhBMP-7 has synergic effects on improving early stage bone formation and subsequently bone quality and quantity of the bone grafts.

[1]  M. Schenker,et al.  Angiogenesis in bone regeneration. , 2011, Injury.

[2]  H. Eufinger,et al.  Growth and transplantation of a custom vascularised bone graft in a man , 2004, The Lancet.

[3]  S. Badylak,et al.  A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.

[4]  Kai Zhang,et al.  Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1α mediated BMSCs. , 2012, Biomaterials.

[5]  H. Terheyden,et al.  Osseointegration--communication of cells. , 2012, Clinical oral implants research.

[6]  Qixin Zheng,et al.  Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous β-TCP ceramic scaffolds , 2006, Biomedical materials.

[7]  Koichi Matsuo,et al.  Osteoclast-osteoblast communication. , 2008, Archives of biochemistry and biophysics.

[8]  Ioannis P. Kostas-Agnantis,et al.  Recent updates of surgical techniques and applications of free vascularized fibular graft in extremity and trunk reconstruction , 2011, Microsurgery.

[9]  J. Kanczler,et al.  Osteogenesis and angiogenesis: the potential for engineering bone. , 2008, European cells & materials.

[10]  Antonios G Mikos,et al.  Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. , 2009, Tissue engineering. Part A.

[11]  H. Yoshikawa,et al.  Synthetic Alginate is a Carrier of OP-1 for Bone Induction , 2009, Clinical orthopaedics and related research.

[12]  Michael J Yaszemski,et al.  Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. , 2009, Biomaterials.

[13]  T. Einhorn,et al.  Bone morphogenetic proteins in orthopaedic surgery. , 2009, Cytokine & growth factor reviews.

[14]  Ali Khademhosseini,et al.  Vascularized bone tissue engineering: approaches for potential improvement. , 2012, Tissue engineering. Part B, Reviews.

[15]  J. Wozney Overview of Bone Morphogenetic Proteins , 2002, Spine.

[16]  A. Nguyen,et al.  Brief review of models of ectopic bone formation. , 2012, Stem cells and development.

[17]  E H Schemitsch,et al.  Fracture vascularity and bone healing: a systematic review of the role of VEGF. , 2008, Injury.

[18]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Theodore Troupis,et al.  Tissue‐engineered vascularized bone grafts: Basic science and clinical relevance to trauma and reconstructive microsurgery , 2011, Microsurgery.

[20]  P. Collin‐Osdoby Role of vascular endothelial cells in bone biology , 1994, Journal of cellular biochemistry.

[21]  J. Urbaniak,et al.  Free vascularized fibular transfer for femoral head osteonecrosis: donor and graft site morbidity. , 2009, The Journal of bone and joint surgery. American volume.

[22]  J. Glowacki Angiogenesis in fracture repair. , 1998, Clinical orthopaedics and related research.

[23]  Jui-Sheng Sun,et al.  The role of muscle-derived stem cells in bone tissue engineering. , 2005, Biomaterials.

[24]  Christoph Dehio,et al.  VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. , 2005, Biochemical and biophysical research communications.

[25]  D. Buchbinder,et al.  Contemporary reconstruction of the mandible. , 2010, Oral oncology.

[26]  Yu-Chen Hu,et al.  The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. , 2010, Biomaterials.

[27]  R. Oreffo,et al.  Skeletal tissue regeneration: current approaches, challenges, and novel reconstructive strategies for an aging population. , 2011, Tissue engineering. Part B, Reviews.

[28]  Antonios G Mikos,et al.  Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. , 2008, Bone.

[29]  H Terheyden,et al.  Prefabrication of vascularized bone grafts using recombinant human osteogenic protein-1--part 3: dosage of rhOP-1, the use of external and internal scaffolds. , 2004, International journal of oral and maxillofacial surgery.

[30]  Karim Oudina,et al.  In vitro and in vivo bioluminescent quantification of viable stem cells in engineered constructs. , 2010, Tissue engineering. Part C, Methods.

[31]  H. Petite,et al.  Ischemia is the prime but not the only cause of human multipotent stromal cell death in tissue-engineered constructs in vivo. , 2012, Tissue engineering. Part A.

[32]  N. Sims,et al.  Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. , 2008, Seminars in cell & developmental biology.

[33]  S Jepsen,et al.  Mandibular reconstruction with a prefabricated vascularized bone graft using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part I: Prefabrication. , 2001, International journal of oral and maxillofacial surgery.

[34]  Xin Xu,et al.  Two-step transport-disk distraction osteogenesis in reconstruction of mandibular defect involving body and ramus. , 2010, International journal of oral and maxillofacial surgery.

[35]  R. Knuechel,et al.  The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. , 2010, Biomaterials.

[36]  Joseph P Vacanti,et al.  Reconstruction of mandibular defects with autologous tissue-engineered bone. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[37]  M. Montjovent,et al.  UvA-DARE ( Digital Academic Repository ) VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo , 2010 .

[38]  P. Sieg,et al.  Long-term evaluation of donor site morbidity after free fibula transfer. , 2010, The British journal of oral & maxillofacial surgery.

[39]  Takaaki Tanaka,et al.  Repair of segmental bone defects in rabbit tibiae using a complex of beta-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. , 2006, Biomaterials.

[40]  Klaus Ludwig,et al.  The mechanical integrity of in vivo engineered heterotopic bone. , 2006, Biomaterials.